McIlrath & Eck’s Safeguard Scientifics, Inc. SFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-33
| Closed | -$26 | – | 973 |
|
|
2023
Q4 | $26 | Hold |
33
| – | – | ﹤0.01% | 923 |
|
|
2023
Q3 | $33 | Hold |
33
| – | – | ﹤0.01% | 880 |
|
|
2023
Q2 | $54 | Hold |
33
| – | – | ﹤0.01% | 885 |
|
|
2023
Q1 | $57 | Hold |
33
| – | – | ﹤0.01% | 914 |
|
|
2022
Q4 | $102 | Hold |
33
| – | – | ﹤0.01% | 865 |
|
|
2022
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 913 |
|
|
2022
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 888 |
|
|
2022
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 850 |
|
|
2021
Q4 | $0 | Hold |
33
| – | – | ﹤0.01% | 853 |
|
|
2021
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 846 |
|
|
2021
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 841 |
|
|
2021
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 794 |
|
|
2020
Q4 | $0 | Hold |
33
| – | – | ﹤0.01% | 717 |
|
|
2020
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 727 |
|
|
2020
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 732 |
|
|
2020
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 716 |
|
|
2019
Q4 | $0 | Hold |
33
| – | – | ﹤0.01% | 668 |
|
|
2019
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 677 |
|
|
2019
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 638 |
|
|
2019
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 648 |
|
|
2018
Q4 | $0 | Hold |
33
| – | – | ﹤0.01% | 594 |
|
|
2018
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 583 |
|
|
2018
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 566 |
|
|
2018
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 539 |
|
|
2017
Q4 | $0 | Buy |
+33
| New | +$423 | ﹤0.01% | 555 |
|
Other funds holding SFE
CP
RA
FWM
HNB
McIlrath & Eck's SFE Position: Q1 2024 in Review
McIlrath & Eck sold out of Safeguard Scientifics, Inc. (SFE) in Q1 2024, closing a stake of 33 shares — an estimated $26 sold.
McIlrath & Eck first reported a position in SFE in Q4 2017 and held it in 25 quarters. The position peaked at $102 in Q4 2022. 4 funds tracked by Wall St. Rank hold SFE as of Q1 2024.
- McIlrath & Eck reported no remaining Safeguard Scientifics, Inc. position as of Q1 2024 after selling out during the quarter.
- McIlrath & Eck sold 33 Safeguard Scientifics, Inc. shares in Q1 2024, an estimated $26.
- McIlrath & Eck first reported a position in Safeguard Scientifics, Inc. in Q4 2017 and held it in 25 quarters.
- McIlrath & Eck's Safeguard Scientifics, Inc. position peaked at $102 in Q4 2022.
- 4 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q1 2024.
Based on McIlrath & Eck's 13F filing for Q1 2024, filed 10 May 2024.